MedTrace Logo

Immediate Postpartum Insertion of Contraceptive Intrauterine Devices

NCT03657602 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2023-04-25

No results posted yet for this study

Summary

In this randomized trial, investigators intend to determine the expulsion and discontinuation rate of immediate postpartum intrauterine devices in the patient population of the University of Oklahoma Women's Healthcare Specialists Clinic (OUWHSC).

Conditions

  • Contraception

Interventions

DRUG

Kyleena Intrauterine System

Participant will be randomly allocated to this intervention

DRUG

Mirena Intrauterine System

Participant will be randomly allocated to this intervention

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Valorie Owens, MSW · University of Oklahoma

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-15
Primary Completion
2023-01-15
Completion
2023-01-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03657602 on ClinicalTrials.gov